$4835 | Single User
$5180 | Site License
$7020 | Enterprise License

Asia-Pacific Next Generation Sequencing (NGS) market by Product - (software and services) by Technology – (whole targeted re-sequencing, genome sequencing, de novo sequencing, exome sequencing, RNA-Seq, ChIP-Seq and Methyl-Seq)by application – (diagnostics, drug discovery, biomarker discovery, personalized medicine, and agriculture and animals research) and by Region - Industry Analysis, Size,
[Lowest Price Guaranteed: $4,835]

Published by Market Data Forecast: 01 Dec 2016 | 49366 | In Stock
Related Topics: Bioscience , Life , Roche , Software

Introduction

The Asia-Pacific NGS market which was worth $ 567.7 million in 2016 is poised to reach

,636.7 million by 2021 at a CAGR of 23.59%. Asia presents significant opportunities for the

investors/venture capitalists as the developed markets are saturated. The presence of noteworthy

developments by China and Japan for integration of new technologies and the development of

healthcare is majorly driving the Asia Pacific Market.

R&D and clinical development frameworks of countries such as India and Australia have

composed the Asia Pacific market to witness a lucrative growth throughout the forecast period.

Rise in growth of personalized medicine, development in pre-sequencing and NGS bioinformatics

solutions and cloud computing, increasing research in oncology are few factors driving the market

growth. In addition, anticipated decrease in the prices of genome sequencing due to development

of rapid, high capacity whole genome sequencers by key players is expected to have an optimistic

effect on market penetration rates over the few years. However, the storage and management of

enormous data generated by sequencing and its interpretation, high reliability on grants & funding

from the government and fall in capital expenditure from academic institutions are some of the

challenges for Asia-Pacific next generation sequencing market

The Next Generation Sequencing market is categorized by type (product and services) and

by technology such as whole targeted re-sequencing, genome sequencing, exome sequencing, de

novo sequencing, RNA-Seq, ChIP-Seq and Methyl-Seq. And by application it is segmented into

diagnostics, drug discovery, biomarker discovery, personalized medicine, and agriculture and

animals research. Further, based on end users the market is segmented as Academic Institutions

and Research Centers, Hospitals/Clinical Laboratories, Biotech/Pharma Companies and others. On

the basis of geography, the Asia-Pacific market is segmented into regions namely, China, India,

Japan, South Korea, Taiwan, Indonesia, Malaysia, Singapore and Thailand.

Asia-Pacific Next Generation Sequencing (NGS) Market Page | 2

Key players in Asia Pacific Next Generation Sequencing Market include Illumina

Incorporated, Thermo Fischer Scientific, Life Sciences (Roche), Pacific Biosciences, Macrogen Inc.,

Partek Inc., Genomatix Software GmbH, Perkin Elmer inc., DNASTAR Inc., and Qiagen N.V.

Table of Contents
for Asia-Pacific Next Generation Sequencing (NGS) market by Product - (software and services) by Technology – (whole targeted re-sequencing, genome sequencing, de novo sequencing, exome sequencing, RNA-Seq, ChIP-Seq and Methyl-Seq)by application – (diagnostics, drug discovery, biomarker discovery, personalized medicine, and agriculture and animals research) and by Region - Industry Analysis, Size,

  • 1. INTRODUCTION

    1.1 Market Definition

    1.2 Study Deliverables

    1.3 Base Currency, Base Year and Forecast Periods

    1.4 General Study Assumptions

    2. RESEARCH METHODOLOGY

    2.1 Introduction

    2.2 Research Phases

    2.2.1 Secondary Research

    2.2.2 Primary Research

    2.2.3 Econometric Modelling

    2.2.4 Expert Validation

    2.3 Analysis Design

    2.4 Study Timeline

    3. OVERVIEW

    3.1 Executive Summary

    3.2 Key Inferences

    4. DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ANALYSIS

    4.1 Market Drivers

    4.2 Market Restraints

    4.3 Key Challenges

    4.4 Current Opportunities in the Market

    [ii]

    5. MARKET SEGMENTATION

    5.1 Introduction

    5.2 APAC NGS Market, By Type

    5.2.1 Products

    5.2.1.1 Instruments and Software

    5.2.1.2 Consumables

    5.2.1.3 Y-o-Y Growth Analysis, By Product

    5.2.1.4 Market Attractiveness Analysis, By Product

    5.2.1.5 Market Share Analysis, By Product

    5.2.2 Services

    5.2.2.1 Sequencing Services

    5.2.2.2 Data Analysis Services

    5.2.2.3 Y-o-Y Growth Analysis, By Service

    5.2.2.4 Market Attractiveness Analysis, By Service

    5.2.2.5 Market Share Analysis, By Service

    5.2.3 Y-o-Y Growth Analysis, By Type

    5.2.4 Market Attractiveness Analysis, By Type

    5.2.5 Market Share Analysis, By Type

    5.3 APAC NGS Market, By Technology

    5.3.1 Whole Targeted Re-Sequencing

    5.3.2 Whole Genome Sequencing

    5.3.3 De Novo Sequencing

    5.3.4 Whole Exome Sequencing

    5.3.5 Transcriptome (RNA-Sequencing)

    [iii]

    5.3.6 ChIP-Sequencing

    5.3.7 Methyl-Sequencing

    5.3.8 Others

    5.3.9 Y-o-Y Growth Analysis, By Technology

    5.3.10 Market Attractiveness Analysis, By Technology

    5.3.11 Market Share Analysis, By Technology

    5.4 APAC NGS Market, By Application

    5.4.1 Diagnostics

    5.4.2 Drug Discovery & Development

    5.4.3 Biomarker Discovery

    5.4.4 Personalized Medicine

    5.4.5 Agriculture and Animal Health Research

    5.4.6 Y-o-Y Growth Analysis, By Application

    5.4.7 Market Attractiveness Analysis, By Application

    5.4.8 Market Share Analysis, By Application

    5.5 APAC NGS Market, By End User

    5.5.1 Academic/Research Institutes

    5.5.2 Hospitals/Clinical Laboratories

    5.5.3 Pharmaceuticals & Biotechnology Companies

    5.5.4 Y-o-Y Growth Analysis, By End User

    5.5.5 Market Attractiveness Analysis, By End User

    5.5.6 Market Share Analysis, By End User

    6. GEOGRAPHICAL ANALYSIS

    6.1 Introduction

    [iv]

    6.2 Asia-Pacific NGS Market, By Country

    6.2.1 Introduction

    6.2.2 India

    6.2.2.1 Introduction

    6.2.2.2 India NGS Market, By Type

    6.2.2.3 India NGS Market, By Technology

    6.2.2.4 India NGS Market, By Application

    6.2.2.5 India NGS Market, By End-User

    6.2.3 China

    6.2.3.1 Introduction

    6.2.3.2 China NGS Market, By Type

    6.2.3.3 China NGS Market, By Technology

    6.2.3.4 China NGS Market, By Application

    6.2.3.5 China NGS Market, By End-User

    6.2.4 Japan

    6.2.4.1 Introduction

    6.2.4.2 Japan NGS Market, By Type

    6.2.4.3 Japan NGS Market, By Technology

    6.2.4.4 Japan NGS Market, By Application

    6.2.4.5 Japan NGS Market, By End-User

    6.2.5 Australia

    6.2.5.1 Introduction

    6.2.5.2 Australia NGS Market, By Type

    6.2.5.3 Australia NGS Market, By Technology

    [v]

    6.2.5.4 Australia NGS Market, By Application

    6.2.5.5 Australia NGS Market, By End-User

    6.2.6 South Korea

    6.2.6.1 Introduction

    6.2.6.2 South Korea NGS Market, By Type

    6.2.6.3 South Korea NGS Market, By Technology

    6.2.6.4 South Korea NGS Market, By Application

    6.2.6.5 South Korea NGS Market, By End-User

    6.2.7 Taiwan

    6.2.7.1 Introduction

    6.2.7.2 Taiwan NGS Market, By Type

    6.2.7.3 Taiwan NGS Market, By Technology

    6.2.7.4 Taiwan NGS Market, By Application

    6.2.7.5 Taiwan NGS Market, By End-User

    6.2.8 Indonesia

    6.2.8.1 Introduction

    6.2.8.2 Indonesia NGS Market, By Type

    6.2.8.3 Indonesia NGS Market, By Technology

    6.2.8.4 Indonesia NGS Market, By Application

    6.2.8.5 Indonesia NGS Market, By End-User

    6.2.9 Malaysia

    6.2.9.1 Introduction

    6.2.9.2 Malaysia NGS Market, By Type

    6.2.9.3 Malaysia NGS Market, By Technology

    [vi]

    6.2.9.4 Malaysia NGS Market, By Application

    6.2.9.5 Malaysia NGS Market, By End-User

    6.2.10 Singapore

    6.2.10.1 Introduction

    6.2.10.2 Singapore NGS Market, By Type

    6.2.10.3 Singapore NGS Market, By Technology

    6.2.10.4 Singapore NGS Market, By Application

    6.2.10.5 Singapore NGS Market, By End-User

    6.2.11 Thailand

    6.2.11.1 Introduction

    6.2.11.2 Thailand NGS Market, By Type

    6.2.11.3 Thailand NGS Market, By Technology

    6.2.11.4 Thailand NGS Market, By Application

    6.2.11.5 Thailand NGS Market, By End-User

    7. STRATEGIC ANALYSIS

    7.1 PESTLE analysis

    7.1.1 Political

    7.1.2 Economic

    7.1.3 Social

    7.1.4 Technological

    7.1.5 Legal

    7.1.6 Ethical

    7.2 Porter’s Five analysis

    7.2.1 Threat of New Entrants

    [vii]

    7.2.2 Threat of Substitute Products and Services

    7.2.3 Bargaining Power of Consumers

    7.2.4 Bargaining Power of Suppliers

    7.2.5 Competitive Rivalry within the Industry

    8. MARKET LEADERS' ANALYSIS

    8.1 Illumina

    8.1.1 Overview

    8.1.2 Products

    8.1.3 Financials

    8.1.4 Recent Developments

    8.1.5 SWOT analysis

    8.1.6 Analyst View

    8.2 Thermo Fisher Scientific

    8.2.1 Overview

    8.2.2 Products

    8.2.3 Financials

    8.2.4 Recent Developments

    8.2.5 SWOT analysis

    8.2.6 Analyst View

    8.3 Qiagen

    8.3.1 Overview

    8.3.2 Products

    8.3.3 Financials

    8.3.4 Recent Developments

    [viii]

    8.3.5 SWOT analysis

    8.3.6 Analyst View

    8.4 Roche

    8.4.1 Overview

    8.4.2 Products

    8.4.3 Financials

    8.4.4 Recent Developments

    8.4.5 SWOT analysis

    8.4.6 Analyst View

    8.5 Macrogen

    8.5.1 Overview

    8.5.2 Products

    8.5.3 Financials

    8.5.4 Recent Developments

    8.5.5 SWOT analysis

    8.5.6 Analyst View

    8.6 Perkin Elmer

    8.6.1 Overview

    8.6.2 Products

    8.6.3 Financials

    8.6.4 Recent Developments

    8.6.5 SWOT analysis

    8.6.6 Analyst View

    8.7 Pacific Biosciences

    8.7.1 Overview

    8.7.2 Products

    8.7.3 Financials

    8.7.4 Recent Developments

    8.7.5 Analyst View

    8.8 Partek Inc.

    8.8.1 Overview

    8.8.2 Products

    8.8.3 Analyst View

    8.9 Genomatix Software GmbH

    8.9.1 Overview

    8.9.2 Products

    8.9.3 Analyst View

    8.10 DNASTAR

    8.10.1 Overview

    8.10.2 Products

    8.10.3 Analyst View

    9. COMPETITIVE LANDSCAPE

    9.1 Market share analysis

    9.2 Merger and Acquisition Analysis

    9.3 Agreements, collaborations and Joint Ventures

    9.4 New Product Launches

    10. MARKET OUTLOOK

Additional Details

Publisher

Market Data Forecast

Publisher Information

Market Data Forecast [MDF] is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extensive research. 

Reference

49366 | Asia-Pacific Next Generation Sequencing (NGS) market

Number of Pages

138

Report Format

PDF

Market Data Forecast Reports

Related Reports

TitleDate PublishedPrice fromMore Details
A. Menarini Asia-Pacific Holdings Pte. Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryA. Menarini Asia-Pacific Holdings Pte. Ltd. (A. Menarini Asia-Pacific), formerly Invida Group...
29 Jul 2016 by Global Data USD $250 More Info
Zuellig Pharma Asia Pacific Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryZuellig Pharma Asia Pacific Ltd. (Zuellig Pharma) is a healthcare service provider that provi...
13 May 2016 by Global Data USD $250 More Info
A. Menarini Asia-Pacific Holdings Pte. Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryA. Menarini Asia-Pacific Holdings Pte. Ltd. (A. Menarini Asia-Pacific), formerly Invida Group...
05 May 2016 by Global Data USD $250 More Info
Zuellig Pharma Asia Pacific Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryZuellig Pharma Asia Pacific Ltd. (Zuellig Pharma) is a healthcare service provider that provi...
17 Mar 2016 by Global Data USD $250 More Info
A. Menarini Asia-Pacific Holdings Pte. Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryA. Menarini Asia-Pacific Holdings Pte. Ltd. (A. Menarini Asia-Pacific), formerly Invida Group...
08 Mar 2016 by Global Data USD $250 More Info
Asia-Pacific Hip Replacement Procedures Outlook to 2021
Asia-Pacific Hip Replacement Procedures Outlook to 2021SummaryGlobalData’s new report, "Asia-Pacific...
05 Oct 2015 by Global Data USD $1,500 More Info
Asia-Pacific Knee Replacement Procedures Outlook to 2021
Asia-Pacific Knee Replacement Procedures Outlook to 2021SummaryGlobalData’s new report, "Asia-Pacifi...
05 Oct 2015 by Global Data USD $1,500 More Info
Asia-Pacific Shoulder Replacement Procedures Outlook to 2021
Asia-Pacific Shoulder Replacement Procedures Outlook to 2021SummaryGlobalData’s new report, "Asia-Pa...
01 Oct 2015 by Global Data USD $1,500 More Info
Asia-Pacific Small Joints Procedures Outlook to 2021
Asia-Pacific Small Joints Procedures Outlook to 2021SummaryGlobalData’s new report, "Asia-Pacific Sm...
01 Oct 2015 by Global Data USD $1,500 More Info
Branded Generics in South East Asia: Current and Future Opportunities
IntroductionWith its fast-growing, young population and projected pharmaceutical sales in excess of ...
01 Apr 2012 by FirstWord Pharma USD $945 More Info

This report is published by Market Data Forecast

Market Data Forecast [MDF] is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extensive research. 

Download Free Report Summary PDF

Asia-Pacific Next Generation Sequencing (NGS) market by Product - (software and services) by Technology – (whole targeted re-sequencing, genome sequencing, de novo sequencing, exome sequencing, RNA-Seq, ChIP-Seq and Methyl-Seq)by application – (diagnostics, drug discovery, biomarker discovery, personalized medicine, and agriculture and animals research) and by Region - Industry Analysis, Size, | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...